Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Short Bowel Syndrome peptide evidence brief
A cited Short Bowel Syndrome peptide evidence brief across 25 exact-label ClinicalTrials.gov records, 3 connected profiles, and 8 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
25 selected records.
3 profiles.
2016–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Short Bowel Syndrome?
PeptideScanner’s selected collection contains 25 retained ClinicalTrials.gov records carrying the exact condition label “Short Bowel Syndrome,” connected to 3 peptide profiles across 8 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Short Bowel Syndrome, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Short Bowel Syndrome unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Short Bowel Syndrome.
Teduglutide · source record 2026-02-08
Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study.
PubMed lists PMID 41647102 in Intestinal Failure (New York, N.Y.) as Journal Article, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Glepaglutide · source record 2026-09-02
Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS-1 phase 3 trial.
PubMed lists PMID 41816796 in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug glepaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teduglutide · source record 2026-01-27
Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).
PubMed lists PMID 35654733 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Journal Article, Review, Consensus Statement, with publication-date metadata of 2022-05-31 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teduglutide · source record 2026-01-27
Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.
PubMed lists PMID 36177820 in Revista espanola de enfermedades digestivas as Case Reports, Journal Article, with publication-date metadata of 2023-06 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teduglutide · source record 2026-01-27
Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
PubMed lists PMID 37001195 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, with publication-date metadata of 2023-03-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teduglutide · source record 2026-01-27
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
PubMed lists PMID 37270288 in The American journal of clinical nutrition as Journal Article, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03690206
PeptideScanner retained ClinicalTrials.gov record NCT03690206 at 2026-11-16T01:46:56.290Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was glepaglutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- July 17, 2025
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03905707
PeptideScanner retained ClinicalTrials.gov record NCT03905707 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 8, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT04627025
PeptideScanner retained ClinicalTrials.gov record NCT04627025 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was apraglutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 27, 2024
- Evidence lane
- Clinical trials
Exact-record source chronology
Short Bowel Syndrome registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
4 recordsGlepaglutide · 2026-09-29
ClinicalTrials.gov record NCT07197944
Recruiting at the retained observation.
Open cited registry record →Glepaglutide · 2026-09-08
ClinicalTrials.gov record NCT03905707
Completed at the retained observation.
Open cited registry record →Glepaglutide · 2026-09-08
ClinicalTrials.gov record NCT04881825
Completed at the retained observation.
Open cited registry record →Teduglutide · 2026-09-08
ClinicalTrials.gov record NCT06973304
Active, not recruiting at the retained observation.
Open cited registry record →2025
5 recordsTeduglutide · 2025-09-11
ClinicalTrials.gov record NCT03562130
Completed at the retained observation.
Open cited registry record →Glepaglutide · 2025-07-17
ClinicalTrials.gov record NCT03690206
Completed at the retained observation.
Open cited registry record →Apraglutide · 2025-07-02
ClinicalTrials.gov record NCT05018286
Active, not recruiting at the retained observation.
Open cited registry record →Apraglutide · 2025-06-18
ClinicalTrials.gov record NCT04964986
Completed at the retained observation.
Open cited registry record →Teduglutide · 2025-03-19
ClinicalTrials.gov record NCT02949362
Completed at the retained observation.
Open cited registry record →2024
3 recordsApraglutide · 2024-11-27
ClinicalTrials.gov record NCT04627025
Completed at the retained observation.
Open cited registry record →Glepaglutide · 2024-11-22
ClinicalTrials.gov record NCT04991311
Completed at the retained observation.
Open cited registry record →Teduglutide · 2024-05-16
ClinicalTrials.gov record NCT05027308
Completed at the retained observation.
Open cited registry record →2023
1 recordTeduglutide · 2023-03-15
ClinicalTrials.gov record NCT03596164
Completed at the retained observation.
Open cited registry record →2022
2 recordsTeduglutide · 2022-05-24
ClinicalTrials.gov record NCT03268811
Completed at the retained observation.
Open cited registry record →Teduglutide · 2022-02-02
ClinicalTrials.gov record NCT02980666
Completed at the retained observation.
Open cited registry record →2021
8 recordsTeduglutide · 2021-06-11
ClinicalTrials.gov record NCT00930644
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-06-10
ClinicalTrials.gov record NCT01560403
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-06-09
ClinicalTrials.gov record NCT00081458
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-06-09
ClinicalTrials.gov record NCT01952080
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-06-09
ClinicalTrials.gov record NCT02340819
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-06-03
ClinicalTrials.gov record NCT00798967
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-06-02
ClinicalTrials.gov record NCT00172185
Completed at the retained observation.
Open cited registry record →Teduglutide · 2021-05-11
ClinicalTrials.gov record NCT03571516
Completed at the retained observation.
Open cited registry record →2020
1 recordTeduglutide · 2020-08-04
ClinicalTrials.gov record NCT03663582
Completed at the retained observation.
Open cited registry record →2016
1 recordTeduglutide · 2016-02-22
ClinicalTrials.gov record NCT02099084
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.